T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Korn Ferry
KFY
$4.36B
| $21M | ﹤0.01% |
361,305
-105,112
| -23% | -$6.38M |
|
1152
Caesars Entertainment
CZR
$6.04B
| $20.8M | ﹤0.01% |
542,076
-10,182
| -2% | -$567K |
|
1153
Haemonetics
HAE
$4.11B
| $20.7M | ﹤0.01% |
317,619
+33,266
| +12% | +$1.97M |
|
1154
Wayfair
W
$13.9B
| $20.6M | ﹤0.01% |
472,225
-208,300
| -31% | -$14.6M |
|
1155
Service Corp International
SCI
$11.3B
| $20.5M | ﹤0.01% |
296,220
-30,631
| -9% | -$2.09M |
|
1156
Ardagh Metal Packaging
AMBP
$3.16B
| $20.4M | ﹤0.01% |
3,344,089
-11,547,674
| -78% | -$78.1M |
|
|
HIBB
1157
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $20.4M | ﹤0.01% |
466,503
-8,533
| -2% | -$394K |
|
1158
Celanese
CE
$4.86B
| $19.9M | ﹤0.01% |
168,929
-14,170
| -8% | -$2.03M |
|
|
SWCH
1159
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $19.9M | ﹤0.01% |
593,054
+191,333
| +48% | +$6.18M |
|
1160
Principal Financial Group
PFG
$24.6B
| $19.7M | ﹤0.01% |
295,385
-47,767
| -14% | -$3.36M |
|
|
MASI
1161
DELISTED
Masimo
MASI
| $19.7M | ﹤0.01% |
150,534
+50,828
| +51% | +$6.8M |
|
|
EVRI
1162
DELISTED
Everi Holdings
EVRI
| $19.6M | ﹤0.01% |
1,200,091
+46,507
| +4% | +$818K |
|
1163
Omnicom Group
OMC
$24.2B
| $19.6M | ﹤0.01% |
307,614
-27,131
| -8% | -$2.01M |
|
1164
Cytokinetics
CYTK
$10.2B
| $19.6M | ﹤0.01% |
497,739
+35,256
| +8% | +$1.42M |
|
1165
Evergy
EVRG
$19.3B
| $19.5M | ﹤0.01% |
298,902
-34,722
| -10% | -$2.35M |
|
1166
SolarEdge
SEDG
$1.98B
| $19.5M | ﹤0.01% |
71,146
-4,642
| -6% | -$1.27M |
|
1167
Rocket Pharmaceuticals
RCKT
$367M
| $19.4M | ﹤0.01% |
1,407,349
-1,095,037
| -44% | -$13.1M |
|
|
GRMN
1168
Garmin
GRMN
$60.2B
| $19.4M | ﹤0.01% |
196,989
-17,846
| -8% | -$1.88M |
|
|
SLGC
1169
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $19.3M | ﹤0.01% |
4,269,425
-1,567,589
| -27% | -$9.33M |
|
1170
Royal Gold
RGLD
$19.1B
| $19.2M | ﹤0.01% |
179,746
+62,991
| +54% | +$7.79M |
|
1171
Uber
UBER
$155B
| $19.2M | ﹤0.01% |
936,187
+24,995
| +3% | +$664K |
|
|
ICVX
1172
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $19.2M | ﹤0.01% |
3,342,470
+1,506,613
| +82% | +$11.8M |
|
1173
Alliant Energy
LNT
$18.2B
| $19.1M | ﹤0.01% |
325,950
-29,220
| -8% | -$1.76M |
|
1174
Dick's Sporting Goods
DKS
$18.1B
| $19M | ﹤0.01% |
252,581
-53,455
| -17% | -$4.75M |
|
1175
Tenaya Therapeutics
TNYA
$164M
| $19M | ﹤0.01% |
3,366,780
+335,378
| +11% | +$2.71M |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.